BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17053895)

  • 1. The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
    McGready R; Stepniewska K; Lindegardh N; Ashley EA; La Y; Singhasivanon P; White NJ; Nosten F
    Eur J Clin Pharmacol; 2006 Dec; 62(12):1021-31. PubMed ID: 17053895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
    Tarning J; McGready R; Lindegardh N; Ashley EA; Pimanpanarak M; Kamanikom B; Annerberg A; Day NP; Stepniewska K; Singhasivanon P; White NJ; Nosten F
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3837-46. PubMed ID: 19564366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania.
    Mosha D; Guidi M; Mwingira F; Abdulla S; Mercier T; Decosterd LA; Csajka C; Genton B
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4583-92. PubMed ID: 24867986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria.
    Nyunt MM; Nguyen VK; Kajubi R; Huang L; Ssebuliba J; Kiconco S; Mwima MW; Achan J; Aweeka F; Parikh S; Mwebaza N
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1274-82. PubMed ID: 26666942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
    McGready R; Tan SO; Ashley EA; Pimanpanarak M; Viladpai-Nguen J; Phaiphun L; Wüstefeld K; Barends M; Laochan N; Keereecharoen L; Lindegardh N; Singhasivanon P; White NJ; Nosten F
    PLoS Med; 2008 Dec; 5(12):e253. PubMed ID: 19265453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.
    Mutagonda RF; Kamuhabwa AAR; Minzi OMS; Massawe SN; Asghar M; Homann MV; Färnert A; Aklillu E
    Malar J; 2017 Jul; 16(1):267. PubMed ID: 28673292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.
    Lefèvre G; Looareesuwan S; Treeprasertsuk S; Krudsood S; Silachamroon U; Gathmann I; Mull R; Bakshi R
    Am J Trop Med Hyg; 2001; 64(5-6):247-56. PubMed ID: 11463111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.
    Tarning J; Kloprogge F; Dhorda M; Jullien V; Nosten F; White NJ; Guerin PJ; Piola P
    Antimicrob Agents Chemother; 2013 Oct; 57(10):5096-103. PubMed ID: 23917320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania.
    Hietala SF; Mårtensson A; Ngasala B; Dahlström S; Lindegårdh N; Annerberg A; Premji Z; Färnert A; Gil P; Björkman A; Ashton M
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4780-8. PubMed ID: 20713675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.
    Kloprogge F; Workman L; Borrmann S; Tékété M; Lefèvre G; Hamed K; Piola P; Ursing J; Kofoed PE; Mårtensson A; Ngasala B; Björkman A; Ashton M; Friberg Hietala S; Aweeka F; Parikh S; Mwai L; Davis TME; Karunajeewa H; Salman S; Checchi F; Fogg C; Newton PN; Mayxay M; Deloron P; Faucher JF; Nosten F; Ashley EA; McGready R; van Vugt M; Proux S; Price RN; Karbwang J; Ezzet F; Bakshi R; Stepniewska K; White NJ; Guerin PJ; Barnes KI; Tarning J
    PLoS Med; 2018 Jun; 15(6):e1002579. PubMed ID: 29894518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the pharmacokinetics of Coartem.
    Djimdé A; Lefèvre G
    Malar J; 2009 Oct; 8 Suppl 1(Suppl 1):S4. PubMed ID: 19818171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population Pharmacokinetics of Artemether, Dihydroartemisinin, and Lumefantrine in Rwandese Pregnant Women Treated for Uncomplicated Plasmodium falciparum Malaria.
    Lohy Das J; Rulisa S; de Vries PJ; Mens PF; Kaligirwa N; Agaba S; Tarning J; Karlsson MO; Dorlo TPC
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lumefantrine and Desbutyl-Lumefantrine Population Pharmacokinetic-Pharmacodynamic Relationships in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria on the Thailand-Myanmar Border.
    Kloprogge F; McGready R; Hanpithakpong W; Blessborn D; Day NP; White NJ; Nosten F; Tarning J
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6375-84. PubMed ID: 26239986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
    Tarning J; Kloprogge F; Piola P; Dhorda M; Muwanga S; Turyakira E; Nuengchamnong N; Nosten F; Day NP; White NJ; Guerin PJ; Lindegardh N
    Malar J; 2012 Aug; 11():293. PubMed ID: 22913677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria.
    Ezzet F; van Vugt M; Nosten F; Looareesuwan S; White NJ
    Antimicrob Agents Chemother; 2000 Mar; 44(3):697-704. PubMed ID: 10681341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria.
    Salman S; Page-Sharp M; Griffin S; Kose K; Siba PM; Ilett KF; Mueller I; Davis TM
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5306-13. PubMed ID: 21876056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria.
    Djimdé AA; Tekete M; Abdulla S; Lyimo J; Bassat Q; Mandomando I; Lefèvre G; Borrmann S;
    Antimicrob Agents Chemother; 2011 Sep; 55(9):3994-9. PubMed ID: 21670177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction trial between artemether-lumefantrine (Riamet) and quinine in healthy subjects.
    Lefèvre G; Carpenter P; Souppart C; Schmidli H; Martin JM; Lane A; Ward C; Amakye D
    J Clin Pharmacol; 2002 Oct; 42(10):1147-58. PubMed ID: 12362930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coartemether (artemether and lumefantrine): an oral antimalarial drug.
    Wernsdorfer WH
    Expert Rev Anti Infect Ther; 2004 Apr; 2(2):181-96. PubMed ID: 15482185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria.
    Tchaparian E; Sambol NC; Arinaitwe E; McCormack SA; Bigira V; Wanzira H; Muhindo M; Creek DJ; Sukumar N; Blessborn D; Tappero JW; Kakuru A; Bergqvist Y; Aweeka FT; Parikh S
    J Infect Dis; 2016 Oct; 214(8):1243-51. PubMed ID: 27471317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.